Morgan Stanley Standard Biotools Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Standard Biotools Inc. stock. As of the latest transaction made, Morgan Stanley holds 15,245,461 shares of LAB stock, worth $25.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,245,461

Previous 12,934,541 17.87%

Holding current value

$25.3 Million

Previous $22.9 Million 28.52%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.42 - $2.35 $3.28 Million - $5.43 Million	2,310,920 Added 17.87%	15,245,461 $29.4 Million
Q2 2024 Oct 17, 2024	BUY	$1.65 - $2.92 $8.77 Million - $15.5 Million	5,316,665 Added 69.79%	12,934,541 $22.9 Million
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.92 $8.77 Million - $15.5 Million	5,316,665 Added 69.79%	12,934,541 $22.9 Million
Q1 2024 Oct 17, 2024	SELL	$1.87 - $2.78 $9.94 Million - $14.8 Million	-5,316,665 Reduced 41.1%	7,617,876 $20.6 Million
Q1 2024 Aug 16, 2024	BUY	$1.87 - $2.78 $6.9 Million - $10.3 Million	3,689,230 Added 93.91%	7,617,876 $20.6 Million
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $6.9 Million - $10.3 Million	3,689,230 Added 93.91%	7,617,876 $20.6 Million
Q4 2023 Aug 16, 2024	SELL	$1.59 - $2.73 $14.3 Million - $24.6 Million	-9,005,895 Reduced 69.63%	3,928,646 $8.68 Million
Q4 2023 Feb 13, 2024	SELL	$1.59 - $2.73 $834,279 - $1.43 Million	-524,704 Reduced 11.78%	3,928,646 $8.68 Million
Q3 2023 Nov 15, 2023	BUY	$1.9 - $3.05 $2.68 Million - $4.3 Million	1,409,290 Added 46.3%	4,453,350 $12.9 Million
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $223,750 - $389,660	-152,211 Reduced 4.76%	3,044,060 $5.88 Million
Q1 2023 May 15, 2023	BUY	$1.3 - $2.24 $183,652 - $316,447	141,271 Added 4.62%	3,196,271 $6.23 Million
Q4 2022 Feb 14, 2023	BUY	$0.93 - $1.52 $158,087 - $258,380	169,987 Added 5.89%	3,055,000 $3.57 Million
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $237,921 - $445,561	-216,292 Reduced 6.97%	2,885,013 $3.17 Million
Q2 2022 Oct 27, 2022	BUY	$1.6 - $3.99 $226,038 - $563,683	141,274 Added 4.77%	3,101,305 $4.96 Million
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $226,038 - $563,683	141,274 Added 4.77%	3,101,305 $4.96 Million
Q1 2022 Oct 27, 2022	SELL	$2.8 - $3.96 $395,567 - $559,445	-141,274 Reduced 4.56%	2,960,031 $10.6 Million
Q1 2022 May 13, 2022	BUY	$2.8 - $3.96 $7.48 Million - $10.6 Million	2,671,820 Added 927.04%	2,960,031 $10.6 Million
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $4,682 - $7,907	-1,290 Reduced 0.45%	288,211 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $1.59 Million - $2.15 Million	289,501 New	289,501 $1.91 Million

Others Institutions Holding LAB

# of Institutions

143

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account